GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » YoY EPS Growth

Gemina Laboratories (XCNQ:GLAB) YoY EPS Growth : 66.67% (As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Gemina Laboratories YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Gemina Laboratories's YoY EPS Growth for the quarter that ended in Jan. 2024 was 66.67%.

Gemina Laboratories's Earnings per Share (Diluted) for the three months ended in Jan. 2024 was C$-0.01.

Gemina Laboratories YoY EPS Growth Historical Data

The historical data trend for Gemina Laboratories's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories YoY EPS Growth Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24
YoY EPS Growth
- - - 30.00

Gemina Laboratories Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -50.00 -100.00 33.33 - 66.67

Gemina Laboratories YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Gemina Laboratories's YoY EPS Growth for the fiscal year that ended in Jan. 2024 is calculated as:

YoY EPS Growth (A: Jan. 2024 )
=(Earnings per Share (Diluted) (A: Jan. 2024 )-Earnings per Share (Diluted) (A: Jan. 2023 ))/ | Earnings per Share (Diluted) (A: Jan. 2023 ) |
=(-0.07--0.1)/ | -0.1 |
=30.00 %

Gemina Laboratories's YoY EPS Growth for the quarter that ended in Jan. 2024 is calculated as:

YoY EPS Growth (Q: Jan. 2024 )
=(Earnings per Share (Diluted) (Q: Jan. 2024 )-Earnings per Share (Diluted) (Q: Jan. 2023 )) / | Earnings per Share (Diluted) (Q: Jan. 2023 )) |
=(-0.01--0.03)/ | -0.03 |
=66.67 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gemina Laboratories YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Gemina Laboratories (XCNQ:GLAB) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (XCNQ:GLAB) » Definitions » YoY EPS Growth
Comparable Companies
TSX:ATE TSXV:GSD TSX:MBX TSX:TH TSXV:TTI XCNQ:ACOG TSXV:MSCL TSXV:COV TSX:APS TSXV:CZO OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
GLABF:USA
Address
3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Website
https://www.geminalabs.com
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.
Executives
James Damian Tansey Director

Gemina Laboratories (XCNQ:GLAB) Headlines

No Headlines